Back to Newsroom

Puma Biotechnology Announces Positive Outcome of European Opposition Proceedings

LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced that the European Patent Office has upheld the claims in Puma’s licensed European patent (EP 2416774), which were being opposed by Hexal AG.
READ MORE…